REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
NCT05504499
This study is recruiting at 9 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the effectiveness and safety of the use of Aurora Spine ZIP™ MIS Interspinous Fusion System and bone graft material in fusion in patients with chronic low back pain that present with degenerative disc disease with concurrent neurogenic claudication.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Lumbar Spinal Stenosis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Pacific Research Institute
- Last updated on ClinicalTrials.gov
- August 18, 2022
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- The Raso Pain Center · Jupiter, FL
Louisiana · 1
- Koga Neurosurgery · Slidell, LA
Maryland · 1
- National Spine and Pain Centers · Oxon Hill, MD
Nevada · 3
- Comprehensive & Interventional Pain Management · Henderson, NV
- Nevada Advanced Pain Specialists · Reno, NV
- Reno Tahoe Pain Associates · Reno, NV
New Jersey · 1
- The Pain Management Center · Voorhees Township, NJ
Ohio · 1
- Premier Pain Treatment Institute · Loveland, OH
Pennsylvania · 1
- Center for Interventional Pain and Spine · Chadds Ford, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.